Frequency and specificity of red blood cell alloimmunization in chilean transfused patients

Transfusion Medicine and Hemotherapy

Volumn 42, Issue 1, 2015, Pages 4-7

  Caamaño, José ^a,b   Musante, Evangelina ^a,b   Contreras, Margarita ^a   Ulloa, Hernán ^a   Reyes, Carolina ^a   Inaipil, Verónica ^a   Saavedra, Nicolás ^c   Guzmán, Neftalí ^d,e  

^a Hospital Regional de Temuco   (Chile)

^b UNIVERSIDAD SANTO TOMÁS   (Chile)

^c UNIVERSIDAD DE LA FRONTERA   (Chile)

^d UNIVERSIDAD CATÓLICA DE TEMUCO   (Chile)

^e UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Alloimmunization; Red blood cell transfusion; Unexpected antibodies

Indexed keywords

ALLOANTIBODY; FYA ANTIBODY; JKA ANTIBODY; JSB ANTIBODY; K ANTIBODY; LEB ANTIBODY; LUB ANTIBODY; M ANTIBODY; RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY; S ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; BLOOD GROUP TYPING; BLOOD TRANSFUSION REACTION; CANCER PATIENT; CASE CONTROL STUDY; CHILD; CHILEAN; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROENTEROLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RED BLOOD CELL ALLOIMMUNIZATION; RETROSPECTIVE STUDY; SEX RATIO;

EID: 84924931783     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000370136     Document Type: Article

References (22)

1. Poole J, Daniels G: Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007; 21: 58-71.
2. Schonewille H, van de Watering LMG, Loomans DS, Brand A: Red blood cell alloantibodies after transfusion. Factors influencing incidence and specificity. Transfusion 2006; 46: 250-256.
3. Zalpuri S, Zwaginga JJ, le Cessie S, Elshuis J, Schonewille H, van der Bom JG: Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang 2012; 102: 144-149.
4. Alves VM, Martins PR, Soares S, Araújo G, Schmidt LC, Costa SS, Langhi DM, Moraes-Souza H: Alloimmunization screening after transfusion of red blood cells in a prospective study. Rev Bras Hematol Hemoter 2012; 34: 206-211.
5. Wang Q, Yang Q, Bai Y, Zhang C, Diao Y, Fang D: Frequency of RBC alloantibodies in Chinese surgical patients. Transfus Med Hemother 2012; 39: 283-286.
6. Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Briët E: Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007; 47: 2066-2071.
7. Al-Joudi F, Ali AB, Ramli MB, Ahmed S, Ismail M: Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan. Asian J Transfus Sci 2011; 5: 42-45.
8. Cerdas-Quesada C: Specificity of 136 patient's antibodies to human red blood cells in Dr. Max Peralta J Hospital Blood Bank 2004-February 2009. Transfus Apher Sci 2010; 42: 105-108.
9. Moraga M, Rocco P, Miquel J, Nervi F, Llop E, Chakraborty R, Rothhammer F, Carvallo P: Mitochondrial DNA polymorphisms in Chilean aboriginal populations: implications for the peopling of the southern cone of the continent. Am J Phys Anthropol 2000; 113: 19-29.
10. Rocco P, Morales C, Moraga M, Miquel JF, Nervi F, Llop E, Carvallo P, Rothhammer F: Genetic composition of the Chilean population. Analysis of mitochondrial DNA polymorphisms. Rev Med Chil 2002; 130: 125-131.
11. García F, Moraga M, Vera S, Henríquez H, Llop E, Aspillaga E, Rothhammer F: mtDNA microevolution in Southern Chile's archipelagos. Am J Phys Anthropol 2006; 129: 473-481.
12. Gupta R, Singh DK, Singh B, Rusia U: Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci 2011; 45: 167-170.
13. Tatari-Calderone Z, Minniti CP, Kratovil T, Stojakovic M, Vollmer A, Barjaktarevic I, Zhang E, Hoang A, Luban NL, Vukmanovic S: rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. Mol Immunol 2009; 47: 64-70.
14. Thakral B, Saluja K, Sharma RR, Marwaha N: Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Hematology 2008; 13: 313-318.
15. Natukunda B, Schonewille H, van de Watering L, Brand A: Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang 2010; 98: 167-171.
16. Schonewille H, Haak HL, van Zijl AM: Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999; 39: 763-771.
17. Verduin EP, Brand A, Schonewille H: Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review. Transfus Med Rev 2012; 26: 342-353.
18. Winters JL, Pineda AA, Gorden LD, Bryant SC, Melton LJ, Vamvakas EC, Moore SB: RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001; 41: 1413-1420.
19. Blumberg N, Heal JM, Gettings KF: WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 2003; 43: 945-952.
20. Grimshaw K, Sahler J, Spinelli SL, Phipps RP, Blumberg N: New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells. Transfusion 2011; 51: 874-880.
21. Wang LY, Liang DC, Liu HC, Chang FC, Wang CL, Chan YS, Lin M: Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006; 16: 200-203.
22. Lannan KL, Sahler J, Spinelli SL, Phipps RP, Blumberg N: Transfusion immunomodulation - the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis 2013; 50: 61-68.